Shanghai's first third -party detection platform in China established China's first cell preparation will provide the industry with high -quality, high efficiency, and public welfare third -party testing, and will provide important support for ensuring the quality of cell products.
According to the surging news report, Li Jizong, the director of the Shanghai Biomedical Science and Technology Development Center, Li Jizong on Thursday (November 10) in the afternoon of Shanghai to promote cell therapy scientific and technological innovation and industrial development action plan (2022-2024), Introduced Shanghai cell therapy scientific and technological innovation policy and support platform layout.
Li Jizong said that in terms of scientific and technological innovation, the Shanghai Biomedical Science and Technology Development Center mainly focuses on three aspects: basic research, key technology and core equipment materials.
First, strengthen the prospective layout of basic research, look forward to the research on the advanced cutting -edge and disciplinary field of the new target discovery of immunization, the regulation of the fate of stem cells, and the new type of engineering cell therapy to promote the integration and development of basic research and application of basic research and application., Strengthen the integration with disciplines such as Chinese medicine, promote the construction of a number of key laboratories and technological innovation centers for cell therapy, and actively plan to lay out major municipal science and technology projects.
Second, strengthen key technology research, strengthen key technologies such as high -throughput target screening, in vitro gene modification system, new carrier delivery technology, high -quality source cell preparation, and traceability of cell productsSingle -cell technology and other cutting -edge technologies, accelerate the innovation and industrialization of cell -related engineering related engineering technology and production technology.
Third, to accelerate the development of core equipment and materials, carry out automated closed cell treatment equipment, process analysis technology (PAT) system and other instrument equipment and functional appraisal reagents, cell medium, virus purification layer analysis filler and other reagentsResearch and application and application of consumables to realize the core equipment and materials of cell therapy production.
In terms of support platform layout, the Shanghai Biomedical Technology Development Center mainly focuses on clinical research and transformation, third -party testing, and product development and preparation.
First, the clinical research transformation platform, further enhance the capacity of cell preparation, storage, testing and research and development service capabilities of the national stem cell transformation resource library, the Chinese Academy of Sciences' cell resource libraries, promote the construction of related cell resource libraries, and use cell treatment for cell therapyEach innovative entity of the industry provides stable, high -quality cell sources and technical services.
The second is the third -party detection platform of cell therapy products, which is benchmarking international standards to optimize the function of enhancing the functional platform and third -party testing service platform of cell preparation.At present, the cell detection module of the biomedical functional platform has been operated normally, and a series of test standards such as sterile testing have been formulated. The first domestic cell preparation third -party testing platform is established, which will provide the industry with high quality, high efficiency, and public welfare.Three -party testing will provide important support for ensuring the quality of cell products.
Third, the cell therapy product research and development and preparation platform. Shanghai builds a city -level cell treatment clinical research public service platform to provide enterprises and medical institutions with research -level and clinical -level cell products, and product quality traceabilityWait for services.
At present, the Shanghai Biomedical Technology Development Center is accelerating the construction of cell treatment product preparation modules. This module is an important part of the functional platform.Production capacity, realize the medical linkage of research and inspection, and further empower cell therapy for scientific and technological innovation and industrial development.
Li Jizong said that this action plan will further strengthen the technology empowerment of the technology, accelerate the transformation of independent innovation leading advantages into industrial advantages, accelerate the high -quality development of cell therapy industries, form scientific and technological innovation in the field of cell therapy andIndustrial development "Shanghai model".
